SISTEMA INTEGRAL DE INFORMACIÓN ACADÉMICA - PÚBLICO

Llerena A.
(Autor externo)

Obras con ISBN:0
Documentos en revistas:15
Colaboraciones en Tesis:0
Patentes:0
Obras con ISBN:No hay obras de este autor.
Documentos en revistas:
1.- An international adult guideline for making Clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and Clozapine levels?????CRP?????????????????????????????(??) (2026)
 
2.- Longitudinal assessment of SNPs rs72552763 and rs622342 in SLC22A1 over HbA1c control among Mexican-Mestizo diabetic type 2 patients (2024)
 
3.- An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levels (2023)
 
4.- Erratum: Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels (Pharmacopsychiatry (2022) 55 2 (73-86)) (2022)
 
5.- Pharmacogenetics of Metformin Transporters Suggests No Association with Therapeutic Inefficacy among Diabetes Type 2 Mexican Patients (2022)
 
6.- Influence of genetic variants and antiepileptic drug co-treatment on lamotrigine plasma concentration in Mexican Mestizo patients with epilepsy (2020)
 
7.- Challenges and Opportunities for Clinical Pharmacogenetic Research Studies in Resource-Limited Settings: Conclusions From the Council for International Organizations of Medical Sciences?Ibero-American Network of Pharmacogenetics and Pharmacogenomics Meeting (2020)
 
8.- Genomic Ancestry, CYP2D6, CYP2C9, and CYP2C19 Among Latin Americans (2020)
 
9.- Pharmacogenetics of adverse reactions to antiepileptic drugs (2018)
 
10.- Relevance of the ancestry for the variability of the Drug-Metabolizing Enzymes CYP2C9, CYP2C19 and CYP2D6 polymorphisms in a multiethnic Costa Rican population (2016)
 
11.- Interethnic variability of pharmacogenetic biomarkers in Mexican healthy volunteers: A report from the RIBEF (Ibero-American Network of Pharmacogenetics and Pharmacogenomics) (2016)
 
12.- Present status and perspective of pharmacogenetics in Mexico (2014)
 
13.- Evaluation of drug-metabolizing enzyme hydroxylation phenotypes in Hispanic populations: The CEIBA cocktail (2013)
 
14.- Pharmacogenetics in Latin American populations: Regulatory aspects, application to herbal medicine, cardiovascular and psychiatric disorders (2012)
 
15.- Pharmacogenetics of the antiepileptic drugs phenytoin and lamotrigine (2011)
 
Colaboraciones en Tesis:No hay tesis de este autor.
Patentes:No hay patentes de este autor.